Nephrocare mHealth Project: Telemonitoring of Blood Pressure

Blood Pressure Clinical Trial

— Nephrocare  

Official title:

Nephrocare mHealth: Improvement of Patient Empowerment and Self-management by the Use of Telemonitoring.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03708666
• Other study ID #: S60335
• Secondary ID: AZGS2017056
• Status: Completed
• Phase: N/A
• Start date: June 1, 2017
• Est. completion date: June 30, 2018

Study information

• Verified date: October 2018
• Source: Universitaire Ziekenhuizen Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Nephrocare mHealth project supports patients with Chronic Kidney Disease with a mobile application and telemonitoring. The application includes the follow-up of blood pressure.

Description:

Patients that are included in the Nephrocare mHealth project send their blood pressure results through an app or online website.

The clinical decision support system will alert the patient, as well as the general practitioner and the hospital when the blood pressure is too high or low. In addition the clinical decision support will calculate monthly averages and all the data are connected with the electronic patient files.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: June 30, 2018
• Est. primary completion date: December 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Dutch-speaking

• Signed and approved informed consent

• Follow-up by nephrology at the University Hospitals Leuven or General Hospital Groeninge

Exclusion Criteria:

• No Dutch-speaking

• Impaired cognitive condition or medically unstable

Related Conditions & MeSH terms

• Blood Pressure
• Chronic Kidney Diseases
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Other:
• Telemonitoring of blood pressure
Blood pressure monitoring at least once a week.

Locations

Country	Name	City	State
Belgium	University Hospitals Leuven	Leuven

Sponsors (2)

Lead Sponsor	Collaborator
Universitaire Ziekenhuizen Leuven	General Hospital Groeninge

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Systolic and diastolic blood pressure under control	Percentage of patients with blood pressure within target limits	6 months
Secondary	Adaptations of treatment	Percentage of change in hypertension therapy	6 months